Impact Factor 2020: 1.226 (@Clarivate Analytics)
5-Year Impact Factor: 2.285 (@Clarivate Analytics)
Immediacy Index: 2.645
  • Users Online: 209
  • Print this page
  • Email this page
This article has been cited by
1Exploring Innovative Leishmaniasis Treatment: Drug Targets from Pre-Clinical to Clinical Findings
Wanessa Santana,Simone S. C. Oliveira,Mariana H. Ramos,André L. S. Santos,Silvio S. Dolabella,Eliana B. Souto,Patrícia Severino,Sona Jain
Chemistry & Biodiversity.2021;18(9)
[DOI]
2Treatment of Cutaneous Leishmaniasis and Insights into Species-Specific Responses: A Narrative Review
Rajamanthrilage Kasun Madusanka,Hermali Silva,Nadira D. Karunaweera
Infectious Diseases and Therapy.2022;11(2)695
[DOI]
3Efficacy of amiodarone and voriconazole combination therapy in cutaneous leishmaniasis in the mice experimentally infected with Leishmania major
S. Bahrami,A. Oryan,E. Bemani
Journal of Infection and Chemotherapy.2021;27(7)984
[DOI]
4Fabrication and Evaluation of Voriconazole Loaded Transethosomal Gel for Enhanced Antifungal and Antileishmanial Activity
Mudassir Farooq,Faisal Usman,Sumera Zaib,Hamid Saeed Shah,Qazi Adnan Jamil,Fatima Akbar Sheikh,Ajmal Khan,Sameh Rabea,Soheir A. A. Hagras,Gaber El-Saber Batiha,Imtiaz Khan
Molecules.2022;27(10)3347
[DOI]